Brief: Oragenics Announces Recent Capital Raise And Warrant Exercises Totaling $21.9 Million And The Redemption Of Its Series C Preferred Stock
12/02/2021 13:53
Feb 12 (Reuters) - Oragenics Inc OGEN.A :
* ORAGENICS ANNOUNCES RECENT CAPITAL RAISE AND WARRANT
EXERCISES
TOTALING $21.9 MILLION AND THE REDEMPTION OF ITS SERIES C
PREFERRED STOCK
Source text for Eikon: ID:nBw1KJRbha
Further company coverage: OGEN.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oragenics
See all newsBrief: Oragenics Reports Continued Clinical Progress, Provides Regulatory And NYSE American Listing Update
Brief: Oragenics Signs Letter Of Intent To License Cardiodialysis™ Technology From Sigyn Therapeutics To Target Tbi-Induced Systemic Inflammation
Brief: Oragenics Inc - Signs Letter Of Intent To License Cardiodialysis From Sigyn Therapeutics - SEC Filing
Brief: Oragenics Activates Second Site In Phase Iia Clinical Trial Of Onp-002 For Concussion And Mild Traumatic Brain Injury.
Brief: Oragenics Enters Settlement Agreement With Ladenburg Thalmann - Sec Filing